Organization of the mouse RNA-specific adenosine deaminase Adar1 gene 5′-region and demonstration of STAT1-independent, STAT2-dependent transcriptional activation by interferon

Virology

Volumn 380, Issue 2, 2008, Pages 338-343

  George, Cyril X ^a   Das, Sonali ^a   Samuel, Charles E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenosine Deaminase Acting on RNA (ADAR); Interferon; Signal Transducers and Activators of Transcription (STAT)

Indexed keywords

ADENOSINE DEAMINASE; INTERFERON; JANUS KINASE 1; P150 PROTEIN; PROTEIN DERIVATIVE; PROTEIN KINASE R; RNA; STAT1 PROTEIN; STAT2 PROTEIN; UNCLASSIFIED DRUG;

ADAR1 GENE; ANIMAL CELL; ARTICLE; CELL LINE; CELL MUTANT; CONTROLLED STUDY; EMBRYO; EXON; GENE; GENE SEQUENCE; GENE STRUCTURE; GENETIC ORGANIZATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INTERFERON INDUCTION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; RODENT; TRANSCRIPTION INITIATION; TRANSIENT TRANSFECTION;

ADENOSINE DEAMINASE; ANIMALS; ARTIFICIAL GENE FUSION; BASE SEQUENCE; BINDING SITES; CELL LINE; CONSERVED SEQUENCE; GENES, REPORTER; HUMANS; INTERFERONS; JANUS KINASE 1; LUCIFERASES; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); RECEPTOR, INTERFERON ALPHA-BETA; SEQUENCE ANALYSIS, DNA; STAT1 TRANSCRIPTION FACTOR; STAT2 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

RODENTIA;

EID: 53249115175     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.07.029     Document Type: Article

References (53)

1. Athanasiadis A., Placido D., Maas S., Brown B.A., Lowenhaupt K., and Rich A. The crystal structure of the Z beta domain of the RNA-editing enzyme ADAR1 reveals distinct conserved surfaces among Z-domains. J. Mol. Biol. 351 (2005) 496-507
2. Bass B.L., Nishikura K., Keller W., Seeburg P.H., Emeson R.B., O'Connell M.A., Samuel C.E., and Herbert A. A standardized nomenclature for adenosine deaminases that act on RNA. RNA 3 (1997) 947-949
3. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R., and Stark G.R. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 6 (2007) 975-990
4. Bouwman P., Göllner H., Elsässer H.P., Eckhoff G., Karis A., Grosveld F., Philipsen S., and Suske G. Transcription factor Sp3 is essential for post-natal survival and late tooth development. EMBO J. 19 (2000) 655-661
5. Cattaneo R. Biased (A/I) hypermutations of animal virus genomes. Curr. Opin. Genet. Dev. 4 (1994) 895-900
6. Cattaneo R., Schmid A., Eschle D., Baczko K., terMeulen V., and Billeter M.A. Biased hypermutation and other genetic changes in defective measles viruses in human brain infections. Cell 55 (1988) 255-265
7. Das S., Ward S.V., Tacke R.S., Suske G., and Samuel C.E. Activation of the RNA-dependent protein kinase PKR promoter in the absence of interferon is dependent upon Sp proteins. J. Biol. Chem. 281 (2006) 3244-3253
8. Gandy S.Z., Linnstaedt S.D., Muralidhar S., Cashman K.A., Rosenthal L.J., and Casey J.L. RNA editing of the HHV-8 Kaposin transcript eliminates its transforming activity and is induced during lytic replication. J. Virol. 81 (2007) 13544-13551
9. George C.X., and Samuel C.E. Human RNA-specific adenosine deaminase ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon inducible. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 4621-4626
10. George C.X., and Samuel C.E. Characterization of the 5'-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene 229 (1999) 203-213
11. George C.X., Wagner M.V., and Samuel C.E. Expression of interferon-inducible RNA adenosine deaminase ADAR1 during pathogen infection and mouse embryo development involves tissue-selective promoter utilization and alternative splicing. J. Biol. Chem. 280 (2005) 15020-15028
12. Hahm B., Trifilo M.J., Zuniga E.I., and Oldstone M.B. Viruses evade the immune system through type I interferon-mediated STAT2-dependent, but STAT1-independent, signaling. Immunity 22 (2005) 247-257
13. Haller O., Kochs G., and Weber F. The interferon response circuit: induction and suppression by pathogenic viruses. Virology 344 (2006) 119-130
14. Higuchi M., Single F.N., Kohler M., Sommer B., Sprengel R., and Seeburg P.H. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 75 (1993) 1361-1370
15. Isaacs A., and Lindenmann J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B. Biol. Sci. 147 (1957) 258-267
16. Jayan G.C., and Casey J.L. Inhibition of hepatitis delta virus RNA editing by short inhibitory RNA-mediated knockdown of ADAR1 but not ADAR2 expression. J. Virol. 76 (2002) 12399-12404
17. Kawakubo K., and Samuel C.E. Human RNA-specific adenosine deaminase (ADAR1) gene specifies transcripts that initiate from a constitutively active alternative promoter. Gene 27 (2000) 165-172
18. Kim U., Wang Y., Sanford T., Zeng Y., and Nishikura K. Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 11457-11461
19. Kuhen K.L., Vessey J.W., and Samuel C.E. Mechanism of interferon action: identification of essential positions within the novel 15-base-pair KCS element required for transcriptional activation of the RNA-dependent protein kinase pkr gene. J. Virol. 72 (1998) 9934-9939
20. Kumar M., and Carmichael G.G. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl. Acad. Sci. U. S. A. 15 (1997) 3542-3547
21. Liu Y., and Samuel C.E. Mechanism of interferon action: functionally distinct RNA-binding and catalytic domains in the interferon-inducible, double-stranded RNA-specific adenosine deaminase. J. Virol. 70 (1996) 1961-1968
22. Liu Y., and Samuel C.E. Editing of glutamate receptor subunit B pre-mRNA by splice-site variants of interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J. Biol. Chem. 274 (1999) 5070-5077
23. Liu Y., George C.X., Patterson J.B., and Samuel C.E. Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase. J. Biol. Chem. 272 (1997) 4419-4428
24. Liu Y., Emeson R.B., and Samuel C.E. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J. Biol. Chem. 274 (1999) 18351-18358
25. Luthman H., and Magnusson G. High efficiency polyoma DNA transfection of chloroquine treated cells. Nucleic Acids Res. 11 (1983) 1295-1308
26. Markle D., Das S., Ward S.V., and Samuel C.E. Functional analysis of the KCS-like element of the interferon-inducible RNA-specific adenosine deaminase ADAR1 promoter. Gene 304 (2003) 143-149
27. Meraz M.A., White J.M., Sheehan K.C., Bach E.A., Rodig S.J., Dighe A.S., Kaplan D.H., Riley J.K., Greenlund A.C., Campbell D., Carver-Moore K., DuBois R.N., Clark R., Aguet M., and Schreiber R.D. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84 (1996) 431-442
28. O'Connell M.A., Krause S., Higuchi M., Hsuan J.J., Totty N.F., Jenny A., and Keller W. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol. Cell. Biol. 15 (1995) 1389-1397
29. Oldstone, M.B.A., in press. Modeling subacute scherosing panencephalitis (SSPE) in a transgenic mouse system: uncoding pathogenesis of disease and illuminating components of immune control. Curr. Topics Microbiol. Immunol. 330.
30. Padgett R.A., Grabowski P.J., Konarska M.M., Seiler S., and Sharp P.A. Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55 (1986) 1119-1150 Review
31. Patterson J.B., and Samuel C.E. Expression and regulation by interferon of a double-stranded RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 15 (1995) 5376-5388
32. Patterson J.B., Thomis D.C., Hans S.L., and Samuel C.E. Mechanism of interferon action. Double-stranded RNA-specific adenosine deaminase from human cells is inducible by alpha and gamma interferons. Virology 210 (1995) 508-511
33. Park C., Li S., Cha E., and Schindler C. Immune response in Stat2 knockout mice. Immunity 13 (2000) 795-804
34. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signaling. Nat. Rev. Immunol. 5 (2005) 375-386
35. Randall R.E., and Goodbourn S. Interferons and viruses: an interplay between induction, signaling, antiviral responses and virus countermeasures. J. Gen. Virol. 89 (2008) 1-47
36. Rodig S.J., Meraz M.A., White J.M., Lampe P.A., Riley J.K., Arthur C.D., King K.L., Sheehan K.C., Yin L., Pennica D., Johnson Jr. E.M., and Schreiber R.D. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses. Cell 93 (1998) 373-383
37. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 14 (2001) 778-809
38. Samuel C.E., and Knutson G.S. Mechanism of interferon action. Kinetics of induction of the antiviral state and protein phosphorylation in mouse fibroblasts treated with natural and cloned interferons. J. Biol. Chem. 257 (1982) 11791-11795
39. Samuel C.E., and Knutson G.S. Mechanism of interferon action: human leukocyte and immune interferons regulate the expression of different genes and induce different antiviral states in human amnion U cells. Virology 130 (1983) 474-484
40. Sarkis P.T., Ying S., Xu R., and Yu X.F. STAT1-independent cell type-specific regulation of antiviral APOBEC3G by IFN-alpha. J. Immunol. 177 (2006) 4530-4540
41. Schindler C., Levy D.E., and Decker T. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282 (2007) 20059-20063
42. Shtrichman R., Heithoff D.M., Mahan M.J., and Samuel C.E. Tissue selectivity of interferon-stimulated gene expression in mice infected with Dam(+) versus Dam(-) Salmonella enterica serovar Typhimurium strains. Infect. Immun. 70 (2002) 5579-5588
43. Stark G.R. How cells respond to interferons revisited: from early history to current complexity. Cytok. Growth Factor Rev. 18 (2007) 418-423
44. Tanaka H., and Samuel C.E. Mechanism of interferon action: structure of the mouse PKR gene encoding the interferon-inducible RNA-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 7995-7999
45. Taylor D.R., Puig M., Darnell M.E., Mihalik K., and Feinstone S.M. New antiviral pathway that mediates hepatitis C virus replicon interferon sensitivity through ADAR1. J. Virol. 79 (2007) 6291-6298
46. Tenoever B.R., Ng S.L., Chua M.A., McWhirter S.M., García-Sastre A., and Maniatis T. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315 (2007) 1274-1278
47. Toth A.M., Zhang P., Das S., George C.X., and Samuel C.E. Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog. Nucleic Acid Res. Mol. Biol. 81 (2006) 369-434
48. Valente L., and Nishikura K. ADAR gene family and A-to-I RNA editing: diverse roles in posttranscriptional gene regulation. Prog. Nucleic Acid Res. Mol. Biol. 79 (2005) 299-338
49. Ward S.V., and Samuel C.E. Regulation of the interferon-inducible PKR kinase gene: the KCS element is a constitutive promoter element that functions in concert with the interferon-stimulated response element. Virology 296 (2002) 136-146
50. Ward S.V., Markle D., Das S., and Samuel C.E. The promoter-proximal KCS element of the PKR kinase gene enhances transcription irrespective of orientation and position relative to the ISRE element and is functionally distint from the KCS-like element of the ADAR deaminase promoter. J. Interferon Cytokine Res. 22 (2002) 891-898
51. Weier H.U., George C.X., Greulich K.M., and Samuel C.E. The interferon-inducible, double-stranded RNA-specific adenosine deaminase gene (DSRAD) maps to human chromosome 1q21.1-21.2. Genomics 30 (1995) 372-375
52. Weier H.U., George C.X., Lersch R.A., Breitweser S., Cheng J.F., and Samuel C.E. Assignment of the RNA-specific adenosine deaminase gene (Adar) to mouse chromosome 3F2 by in situ hybridization. Cytogenet. Cell Genet. 89 (2000) 214-215
53. Zahn R.C., Schelp I., Utermöhlen O., and von Laer D. A-to-G hypermutation in the genome of lymphocytic choriomeningitis virus. J. Virol. 81 (2007) 457-464